BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 17691257)

  • 1. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 9. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
    Ghislain PD; Roujeau JC
    Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.
    Hockett KC
    Clin J Oncol Nurs; 2004 Feb; 8(1):27-30, 55. PubMed ID: 14983759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
    J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.